Determination of ceftazidime in plasma by RP-HPLC and ultraviolet detection

Biomed Chromatogr. 2021 Jul;35(7):e5104. doi: 10.1002/bmc.5104. Epub 2021 Mar 23.

Abstract

A simple high-performance liquid chromatography method for the determination of ceftazidime in plasma has been developed. Using an ultrafiltration technique samples were separated by reverse-phase high-performance liquid chromatography on a Symmetry C18 4.6 × 250 mm column (5.0 μm) and ultraviolet absorbance was measured at 260 nm. The mobile phase was a mixture of 10 mm potassium phosphate monobasic pH 2.5 with phosphoric acid and acetonitrile (90:10). The standard curve ranged from 0.1 to 100 μg/ml. Intra- and inter-assay variability for ceftazidime was <12%, and the average recovery was 89%. The lower limit of quantification was 0.1 μg/ml. This method has been used successfully to analyze frog plasma samples at this institution and it could be applied to other small volume samples in a clinical or research setting.

Keywords: HPLC; UV; ceftazidime; pharmacokinetics.

MeSH terms

  • Ceftazidime / blood*
  • Ceftazidime / chemistry
  • Ceftazidime / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Chromatography, Reverse-Phase / methods*
  • Humans
  • Linear Models
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet / methods*

Substances

  • Ceftazidime